Efficacy and safety of bendamustine plus bortezomib in relapsed/refractory multiple myeloma: A phase I/II trial.
J. R. Berenson
Consultant or Advisory Role - Millennium
Honoraria - Millennium
Research Funding - Cephalon; Millennium
O. Yellin
No relevant relationships to disclose
A. Bessudo
No relevant relationships to disclose
R. Boccia
Research Funding - Center for Cancer and Blood Disorders
S. Noga
Honoraria - Celgene; Centocor Ortho Biotech; Cephalon; Millennium; Takeda
D. Gravenor
Research Funding - Cephalon
D. Patel-Donnelly
No relevant relationships to disclose
R. S. Siegel
Research Funding - Cephalon
T. Kewalramani
No relevant relationships to disclose
E. J. Gorak
No relevant relationships to disclose
R. Swift
Consultant or Advisory Role - Millennium
Honoraria - Millennium
D. Bensen-Kennedy
Employment or Leadership Position - Cephalon
Stock Ownership - Cephalon